Centiva Capital’s Madison Square Garden MSGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$246K Sell
613
-1,953
-76% -$692K ﹤0.01% 1284
2026
Q1
$825K Buy
+2,566
New +$765K 0.01% 654
2023
Q4
Sell
-2,007
Closed -$354K 2089
2023
Q3
$354K Buy
2,007
+441
+28% +$83K 0.01% 1110
2023
Q2
$294K Sell
1,566
-1,849
-54% -$349K 0.01% 1127
2023
Q1
$665K Buy
+3,415
New +$636K 0.02% 735
2022
Q4
Sell
-2,096
Closed -$286K 1534
2022
Q3
$286K Buy
2,096
+497
+31% +$77.1K 0.01% 1062
2022
Q2
$241K Buy
+1,599
New +$260K 0.01% 1209
2020
Q4
Sell
-3,592
Closed -$541K 1035
2020
Q3
$541K Buy
+3,592
New +$564K 0.04% 312

Other funds holding MSGS

Centiva Capital's MSGS Position: Q2 2026 in Review

Centiva Capital reduced its Madison Square Garden (MSGS) stake by 76% in Q2 2026, selling an estimated $692K and leaving 613 shares worth $246K. The position accounts for ﹤0.01% of the portfolio, ranked #1284.

Centiva Capital first reported a position in MSGS in Q3 2020 and has held it in 8 quarters since. The position peaked at $825K in Q1 2026. 468 funds tracked by Wall St. Rank hold MSGS as of Q2 2026.

  • Centiva Capital held 613 shares of Madison Square Garden worth $246K as of Q2 2026.
  • Centiva Capital sold 1,953 Madison Square Garden shares in Q2 2026, an estimated $692K.
  • Madison Square Garden made up ﹤0.01% of Centiva Capital's portfolio in Q2 2026, its #1284 holding.
  • Centiva Capital first reported a position in Madison Square Garden in Q3 2020 and has held it in 8 quarters since.
  • Centiva Capital's Madison Square Garden position peaked at $825K in Q1 2026.
  • 468 funds tracked by Wall St. Rank held Madison Square Garden as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.